{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:00:23Z","timestamp":1782892823454,"version":"3.54.5"},"reference-count":289,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.apsb.2025.04.026","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:18:45Z","timestamp":1745867925000},"page":"4386-4410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Artificial intelligence in drug development for delirium and Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"15","author":[{"given":"Ruixue","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8648-6245","authenticated-orcid":false,"given":"Xianglu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3074-2411","authenticated-orcid":false,"given":"Shenglong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-6700","authenticated-orcid":false,"given":"Leiv Otto","family":"Watne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6511-8219","authenticated-orcid":false,"given":"Geir","family":"Selb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehani","family":"Wedatilake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-5263","authenticated-orcid":false,"given":"David C.","family":"Rubinsztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7896-9135","authenticated-orcid":false,"given":"Jennifer E.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-9146","authenticated-orcid":false,"given":"Bj\u00f8rn Erik","family":"Neerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-7733","authenticated-orcid":false,"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-7202","authenticated-orcid":false,"given":"Evandro Fei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.04.026_bib1","first-page":"716","article-title":"Common molecular and pathophysiological underpinnings of delirium and Alzheimer\u2019s disease: molecular signatures and therapeutic indications","volume":"24","author":"Mosharaf","year":"2024","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.apsb.2025.04.026_bib2","first-page":"90","article-title":"Delirium","volume":"6","author":"Wilson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2025.04.026_bib3","first-page":"101","article-title":"Delirium in elderly people: a review","volume":"3","author":"Martins","year":"2012","journal-title":"Front Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib4","article-title":"Predisposing and precipitating factors associated with delirium: a systematic review","volume":"6","author":"Ormseth","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.apsb.2025.04.026_bib5","first-page":"973","article-title":"Risk factors, preventive interventions, overlapping symptoms, and clinical measures of delirium in elderly patients","volume":"13","author":"Mei","year":"2023","journal-title":"World J Psychiatr"},{"key":"10.1016\/j.apsb.2025.04.026_bib6","first-page":"655","article-title":"Delirium in the elderly: current problems with increasing geriatric age","volume":"142","author":"Kukreja","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib7","first-page":"192","article-title":"Diagnosis of delirium: a practical approach","volume":"23","author":"Alexander","year":"2023","journal-title":"Pract Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib8","first-page":"579","article-title":"The inter-relationship between delirium and dementia: the importance of delirium prevention","volume":"18","author":"Fong","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib9","first-page":"1501","article-title":"The neuropsychology of delirium: advancing the science of delirium assessment","volume":"33","author":"Tieges","year":"2018","journal-title":"Int J Geriatr Psychiatr"},{"key":"10.1016\/j.apsb.2025.04.026_bib10","first-page":"5346","article-title":"Delirium and its association with short- and long-term health outcomes in medically admitted patients: a prospective study","volume":"12","author":"Al Huraizi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib11","first-page":"afae006","article-title":"Delirium is frequently underdiagnosed among older hospitalised patients despite available information in hospital medical records","volume":"53","author":"Titlestad","year":"2024","journal-title":"Age Ageing"},{"issue":"Suppl 2","key":"10.1016\/j.apsb.2025.04.026_bib12","first-page":"S241","article-title":"The importance of delirium: economic and societal costs","volume":"59","author":"Leslie","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.apsb.2025.04.026_bib13","first-page":"1026","article-title":"The economic cost of delirium: a systematic review and quality assessment","volume":"17","author":"Kinchin","year":"2021","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib14","unstructured":"Organization WH. Dementia. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"10.1016\/j.apsb.2025.04.026_bib15","article-title":"Dementia prevention in memory clinics: recommendations from the European task force for brain health services","volume":"26","author":"Frisoni","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.apsb.2025.04.026_bib16","first-page":"32","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.apsb.2025.04.026_bib17","series-title":"2020 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement","year":"2020"},{"key":"10.1016\/j.apsb.2025.04.026_bib18","unstructured":"Organization WH. Dementia: a public health priority. Organization, World Health. Available from: https:\/\/iris.who.int\/handle\/10665\/75263."},{"key":"10.1016\/j.apsb.2025.04.026_bib19","first-page":"1579","article-title":"Distinguishing Alzheimer\u2019s disease from other major forms of dementia","volume":"11","author":"Karantzoulis","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.apsb.2025.04.026_bib20","first-page":"139","article-title":"Epidemiology of aging and associated cognitive disorders: prevalence and incidence of Alzheimer\u2019s disease and other dementias","volume":"167","author":"Lopez","year":"2019","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib21","first-page":"272","article-title":"Alzheimer\u2019s disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib22","first-page":"630","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2025.04.026_bib23","first-page":"719","article-title":"Senolytic therapy alleviates Abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib24","first-page":"401","article-title":"Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib25","first-page":"151","article-title":"Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib26","first-page":"e105","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.apsb.2025.04.026_bib27","first-page":"823","article-title":"The interface between delirium and dementia in elderly adults","volume":"14","author":"Fong","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib28","first-page":"914","article-title":"Recurrent delirium over 12 months predicts dementia: results of the Delirium and Cognitive Impact in Dementia (DECIDE) study","volume":"50","author":"Richardson","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.apsb.2025.04.026_bib29","first-page":"822","article-title":"Delirium and the risk of developing dementia: a cohort study of 12 949 patients","volume":"93","author":"Leighton","year":"2022","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.apsb.2025.04.026_bib30","first-page":"511","article-title":"Delirium is associated with loss of feedback cortical connectivity","volume":"20","author":"Gjini","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib31","first-page":"1306","article-title":"Long-term cognitive impairment after critical illness","volume":"369","author":"Pandharipande","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib32","first-page":"1324","article-title":"Delirium and long-term cognitive trajectory among persons with dementia","volume":"172","author":"Gross","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib33","first-page":"244","article-title":"Association of delirium with cognitive decline in late life: a neuropathologic study of 3 population-based cohort studies","volume":"74","author":"Davis","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.apsb.2025.04.026_bib34","first-page":"2809","article-title":"Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study","volume":"135","author":"Davis","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.apsb.2025.04.026_bib35","first-page":"23","article-title":"Prevalence, risk factors, and impact of delirium on hospitalized older adults with dementia: a systematic review and meta-analysis","volume":"23","author":"Han","year":"2022","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.apsb.2025.04.026_bib36","first-page":"371","article-title":"Preclinical Amyloid-beta and axonal degeneration pathology in delirium","volume":"55","author":"Idland","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.apsb.2025.04.026_bib37","first-page":"3049","article-title":"Why 90% of clinical drug development fails and how to improve it?.","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.04.026_bib38","first-page":"651","article-title":"Drug discovery and development: role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib39","first-page":"203","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.026_bib41","article-title":"Preclinical and clinical evidence of NAD+ precursors in health, disease, and ageing","volume":"199","author":"Reiten","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.apsb.2025.04.026_bib42","first-page":"76","article-title":"Amelioration of Alzheimer\u2019s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow","volume":"6","author":"Xie","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2025.04.026_bib43","first-page":"612","article-title":"Challenges and opportunities in central nervous system drug discovery","volume":"1","author":"Danon","year":"2019","journal-title":"Trends Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib44","series-title":"Forum on neuroscience and nervous system disorders, editors. Improving and accelerating therapeutic development for nervous system disorders: workshop summary","article-title":"Drug development challenges","year":"2014"},{"key":"10.1016\/j.apsb.2025.04.026_bib45","first-page":"426","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology\u2014recommendations from the Global CEO Initiative on Alzheimer\u2019s Disease","volume":"20","author":"Schindler","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib46","article-title":"Current and future therapeutic strategies for Alzheimer\u2019s disease: an overview of drug development bottlenecks","volume":"15","author":"Peng","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib47","first-page":"455","article-title":"Exploring antipsychotic use for delirium management in adults in hospital, sub-acute rehabilitation and aged care settings: a systematic literature review","volume":"41","author":"Tomlinson","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.apsb.2025.04.026_bib48","article-title":"Preventing and treating delirium in clinical settings for older adults","volume":"13","author":"Faeder","year":"2023","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.apsb.2025.04.026_bib50","first-page":"49","article-title":"Artificial intelligence for aging and longevity research: recent advances and perspectives","volume":"49","author":"Zhavoronkov","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib51","first-page":"463","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.026_bib52","first-page":"1241","article-title":"The rise of deep learning in drug discovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib53","first-page":"80","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib54","first-page":"691","article-title":"Artificial intelligence for drug discovery: resources, methods, and applications","volume":"31","author":"Chen","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.apsb.2025.04.026_bib55","first-page":"1798","article-title":"Representation learning: a review and new perspectives","volume":"35","author":"Bengio","year":"2013","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.apsb.2025.04.026_bib56","first-page":"1038","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.04.026_bib57","first-page":"436","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib58","first-page":"891","article-title":"The role of AI in drug discovery: challenges, opportunities, and strategies","volume":"16","author":"Blanco-Gonzalez","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2025.04.026_bib59","first-page":"493","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib60","first-page":"583","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib61","series-title":"GPT-4 technical report","author":"Achiam","year":"2023"},{"key":"10.1016\/j.apsb.2025.04.026_bib62","first-page":"1073","article-title":"Applications of artificial intelligence, machine learning, and deep learning in nutrition: a systematic review","volume":"16","author":"Theodore Armand","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2025.04.026_bib63","first-page":"754","article-title":"Molecular set representation learning","volume":"6","author":"Boulougouri","year":"2024","journal-title":"Nat Mach Intell"},{"key":"10.1016\/j.apsb.2025.04.026_bib64","first-page":"742","article-title":"Extended-connectivity fingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2025.04.026_bib65","series-title":"Neural message passing for quantum chemistry","author":"Gilmer","year":"2017"},{"key":"10.1016\/j.apsb.2025.04.026_bib66","series-title":"Semi-supervised classification with graph convolutional networks","author":"Kipf","year":"2016"},{"key":"10.1016\/j.apsb.2025.04.026_bib67","article-title":"RotNet: a rotationally invariant graph neural network for quantum mechanical calculations","volume":"8","author":"Tu","year":"2024","journal-title":"Small Methods"},{"key":"10.1016\/j.apsb.2025.04.026_bib68","first-page":"4378","article-title":"3D molecular representations based on the wave transform for convolutional neural networks","volume":"15","author":"Kuzminykh","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.04.026_bib69","series-title":"EGformer: equirectangular geometry-biased transformer for 360 depth estimation","author":"Yun","year":"2023"},{"key":"10.1016\/j.apsb.2025.04.026_bib70","article-title":"Simulating 500 million years of evolution with a language model","author":"Hayes","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib71","first-page":"11287","article-title":"Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2","volume":"122","author":"Gao","year":"2022","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib72","article-title":"Tutorial on variational autoencoders","author":"Doersch","year":"2016","journal-title":"ArXiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib73","first-page":"139","article-title":"Generative adversarial networks","volume":"63","author":"Goodfellow","year":"2020","journal-title":"Commun ACM"},{"key":"10.1016\/j.apsb.2025.04.026_bib74","article-title":"Attention is all you need: utilizing attention in AI-enabled drug discovery","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2025.04.026_bib75","first-page":"631","article-title":"Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery","volume":"22","author":"Nayarisseri","year":"2021","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.apsb.2025.04.026_bib76","first-page":"235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib77","first-page":"85","article-title":"Demonstrated health care cost savings for women: findings from a community health worker intervention designed to address depression and unmet social needs","volume":"24","author":"Embick","year":"2021","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.apsb.2025.04.026_bib78","first-page":"btae370","article-title":"RCSB protein Data bank: exploring protein 3D similarities via comprehensive structural alignments","volume":"40","author":"Bittrich","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib79","first-page":"897","article-title":"PIRD: pan immune repertoire database","volume":"36","author":"Zhang","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib81","author":"Risso"},{"key":"10.1016\/j.apsb.2025.04.026_bib82","first-page":"D1243","article-title":"The UCSC Genome Browser database: 2025 update","volume":"53","author":"Perez","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib83","first-page":"61","article-title":"Molecular and imaging biomarkers in Alzheimer\u2019s disease: a focus on recent insights","volume":"10","author":"Villa","year":"2020","journal-title":"J Pers Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib84","first-page":"213","article-title":"Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer\u2019s disease","volume":"16","author":"Meng","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.04.026_bib85","first-page":"4820","article-title":"Omics data and their integrative analysis to support stratified medicine in neurodegenerative diseases","volume":"22","author":"La Cognata","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib86","article-title":"Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation","volume":"20","author":"Richardson","year":"2022","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2025.04.026_bib87","first-page":"1821","article-title":"Disease prediction with multi-omics and biomarkers empowers case-control genetic discoveries in the UK Biobank","volume":"56","author":"Garg","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.04.026_bib88","first-page":"201","article-title":"Alzheimer\u2019s disease neuroimaging initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2025.04.026_bib89","first-page":"1123","article-title":"NIAGADS Alzheimer\u2019s GenomicsDB: a resource for exploring Alzheimer\u2019s disease genetic and genomic knowledge","volume":"20","author":"Greenfest-Allen","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib90","article-title":"The AD Knowledge Portal: a repository for multi-omic data on Alzheimer\u2019s disease and aging","volume":"108","author":"Greenwood","year":"2020","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.apsb.2025.04.026_bib91","first-page":"24","article-title":"AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer\u2019s drug discovery","volume":"13","author":"Zhou","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.04.026_bib92","article-title":"The Alzheimer\u2019s Cell Atlas (TACA): a single-cell molecular map for translational therapeutics accelerator in Alzheimer\u2019s disease","volume":"8","author":"Zhou","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib93","article-title":"The HUNT study: a population-based cohort for genetic research","volume":"2","author":"Brumpton","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/j.apsb.2025.04.026_bib94","first-page":"203","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib95","article-title":"The ROSMAP project: aging and neurodegenerative diseases through omic sciences","volume":"18","author":"Perez-Gonzalez","year":"2024","journal-title":"Front Neuroinf"},{"key":"10.1016\/j.apsb.2025.04.026_bib96","first-page":"64","article-title":"Improving target assessment in biomedical research: the GOT-IT recommendations","volume":"20","author":"Emmerich","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.026_bib97","first-page":"561","article-title":"AI-powered therapeutic target discovery","volume":"44","author":"Pun","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib98","first-page":"398","article-title":"Current and emerging avenues for Alzheimer\u2019s disease drug targets","volume":"286","author":"Loera-Valencia","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib99","article-title":"Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease","volume":"85","author":"Qiu","year":"2024","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.apsb.2025.04.026_bib100","first-page":"4645","article-title":"Innovations in genomics and big data analytics for personalized medicine and health care: a review","volume":"23","author":"Hassan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib101","first-page":"255","article-title":"Machine learning: trends, perspectives, and prospects","volume":"349","author":"Jordan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.026_bib102","first-page":"612","article-title":"Toward causal representation learning","volume":"109","author":"Sch\u00f6lkopf","year":"2021","journal-title":"Proc IEEE"},{"key":"10.1016\/j.apsb.2025.04.026_bib103","first-page":"38","article-title":"Delirium is a risk factor for further cognitive decline in cognitively impaired hip fracture patients","volume":"64","author":"Krogseth","year":"2016","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.apsb.2025.04.026_bib104","first-page":"318","article-title":"Ensemble of deep convolutional neural networks based multi-modality images for Alzheimer\u2019s disease diagnosis","volume":"14","author":"Fang","year":"2020","journal-title":"IET Image Process"},{"key":"10.1016\/j.apsb.2025.04.026_bib105","first-page":"1567","article-title":"The application of artificial intelligence in the genetic study of Alzheimer\u2019s disease","volume":"11","author":"Mishra","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2025.04.026_bib106","first-page":"2","article-title":"Discovery of disease-associated, tau, and inflammatory microglial subpopulations and molecular drivers in Alzheimer\u2019s disease using network-based deep learning integration of human brain single-cell RNA-sequencing data","volume":"19","author":"Cheng","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib107","article-title":"PharmKG: a dedicated knowledge graph benchmark for bomedical data mining","volume":"22","author":"Zheng","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2025.04.026_bib108","first-page":"931","article-title":"Predicting effects of noncoding variants with deep learning-based sequence model","volume":"12","author":"Zhou","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2025.04.026_bib109","first-page":"i121","article-title":"Deep learning of the tissue-regulated splicing code","volume":"30","author":"Leung","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib110","article-title":"AVISPA: a web tool for the prediction and analysis of alternative splicing","volume":"14","author":"Barash","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.apsb.2025.04.026_bib111","first-page":"566","article-title":"Prediction of potential disease-associated micrornas by using neural networks","volume":"16","author":"Zeng","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.apsb.2025.04.026_bib112","series-title":"Molecular machine learning with DeepChem","author":"Ramsundar","year":"2018"},{"key":"10.1016\/j.apsb.2025.04.026_bib113","first-page":"124","article-title":"Exploring the complexity of protein structure determination through X-ray diffraction","volume":"7","author":"Sarah","year":"2023","journal-title":"J Plant Sci Phytopathol"},{"key":"10.1016\/j.apsb.2025.04.026_bib114","first-page":"445","article-title":"Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease","volume":"47","author":"Steinberg","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.04.026_bib115","first-page":"851","article-title":"Challenges with multi-objective QSAR in drug discovery","volume":"13","author":"Lambrinidis","year":"2018","journal-title":"Expet Opin Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.026_bib116","article-title":"Ligandability and druggability assessment via machine learning","volume":"13","author":"Di Palma","year":"2023","journal-title":"WIREs Comput Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib117","author":"Tenenbaum"},{"key":"10.1016\/j.apsb.2025.04.026_bib118","article-title":"Introduction to small molecule drug discovery and preclinical development","volume":"3","author":"Southey","year":"2023","journal-title":"Front Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.026_bib119","first-page":"15936","article-title":"Discovery of high-affinity amyloid ligands using a ligand-based virtual screening pipeline","volume":"145","author":"Chisholm","year":"2023","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2025.04.026_bib120","article-title":"Virtual screening-driven discovery of dual 5-HT6\/5-HT2A receptor ligands with pro-cognitive properties","volume":"185","author":"Staron","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib121","first-page":"663","article-title":"An open-source drug discovery platform enables ultra-large virtual screens","volume":"580","author":"Gorgulla","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib122","article-title":"An AI-driven framework for discovery of BACE1 inhibitors for Alzheimer\u2019s disease","author":"Xie","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib123","series-title":"Multi-objective molecule generation using interpretable substructures","author":"Jin","year":"2020"},{"key":"10.1016\/j.apsb.2025.04.026_bib124","article-title":"Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer\u2019s disease","volume":"41","author":"Xu","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.026_bib125","first-page":"1900","article-title":"Multimodal single-cell\/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer\u2019s disease","volume":"31","author":"Xu","year":"2021","journal-title":"Genome Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib126","first-page":"1033","article-title":"Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.026_bib127","first-page":"1533","article-title":"AI-DrugNet: a network-based deep learning model for drug repurposing and combination therapy in neurological disorders","volume":"21","author":"Pan","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.apsb.2025.04.026_bib128","series-title":"IEEE conference publication, IEEE xplore. 2022 7th international conference on big data analytics (ICBDA)","article-title":"AChEI-EL: prediction of acetylcholinesterase inhibitors based on ensemble learning model","author":"Wang","year":"2022"},{"key":"10.1016\/j.apsb.2025.04.026_bib129","first-page":"201","article-title":"Deep neural network affinity model for BACE inhibitors in D3R Grand Challenge 4","volume":"34","author":"Wang","year":"2020","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2025.04.026_bib130","first-page":"1936","article-title":"Computational modeling of \u03b2-secretase 1 (BACE-1) inhibitors using ligand based approaches","volume":"56","author":"Subramanian","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2025.04.026_bib131","first-page":"60","article-title":"Development of 3D-QSAR model for acetylcholinesterase inhibitors using a combination of fingerprint, molecular docking, and structure-based pharmacophore approaches","volume":"148","author":"Lee","year":"2015","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib132","first-page":"131","article-title":"MathDL: mathematical deep learning for D3R Grand Challenge 4","volume":"34","author":"Nguyen","year":"2020","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2025.04.026_bib133","first-page":"225","article-title":"Affinity prediction using deep learning based on SMILES input for D3R grand challenge 4","volume":"36","author":"Lim","year":"2022","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.apsb.2025.04.026_bib134","first-page":"1135","article-title":"LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM","volume":"37","author":"Shaker","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib135","article-title":"A merged molecular representation deep learning method for blood-brain barrier permeability prediction","volume":"23","author":"Tang","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2025.04.026_bib136","first-page":"1239","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.026_bib137","article-title":"Designing of thiazolidinones against chicken pox, monkey pox, and hepatitis viruses: a computational approach","volume":"103","author":"Raza","year":"2023","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib138","article-title":"Multi-targeted molecular docking, pharmacokinetics, and drug-likeness evaluation of coumarin based compounds targeting proteins involved in development of COVID-19","volume":"29","author":"Mun","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib139","first-page":"279","article-title":"Identification of novel inhibitor against endonuclease subunit of Influenza pH1N1 polymerase: a combined molecular docking, molecular dynamics, MMPBSA, QMMM and ADME studies to combat influenza A viruses","volume":"77","author":"Mohseni","year":"2018","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib140","article-title":"Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: design, synthesis and in vivo studies","volume":"261","author":"Gupta","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib141","article-title":"Design and synthesis of coumarin-triazole hybrids: biocompatible anti-diabetic agents, in silico molecular docking and ADME screening","volume":"6","author":"Channa Basappa","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2025.04.026_bib142","first-page":"2839","article-title":"Virtual screening strategies in drug discovery: a critical review","volume":"20","author":"Lavecchia","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib143","first-page":"107","article-title":"Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of beta-secretase","volume":"68","author":"Palakurti","year":"2017","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib144","first-page":"672","article-title":"Artificial intelligence-enabled virtual screening of ultra-large chemical libraries with deep docking","volume":"17","author":"Gentile","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.apsb.2025.04.026_bib145","article-title":"Identification of new GSK3beta inhibitors through a consensus machine learning-based virtual screening","volume":"24","author":"Galati","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib146","first-page":"1605","article-title":"Deep learning and random forest approach for finding the optimal traditional Chinese medicine formula for treatment of Alzheimer\u2019s disease","volume":"59","author":"Chen","year":"2019","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2025.04.026_bib147","article-title":"EquiFold: protein structure prediction with a novel coarse-grained structure representation","author":"Lee","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib148","first-page":"i268","article-title":"Geometric potentials from deep learning improve prediction of CDR H3 loop structures","volume":"36","author":"Ruffolo","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib149","first-page":"1877","article-title":"ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation","volume":"38","author":"Abanades","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib150","article-title":"Generalized biomolecular modeling and design with RoseTTAFold All-Atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.026_bib151","first-page":"2117","article-title":"ProB-Site: protein binding site prediction using local features","volume":"11","author":"Khan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2025.04.026_bib152","first-page":"363","article-title":"EQUIBIND: a geometric deep learning-based protein\u2013ligand binding prediction method","volume":"17","author":"Li","year":"2023","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.apsb.2025.04.026_bib153","article-title":"TANKBind: trigonometry-aware neural networks for drug\u2013protein binding structure prediction","author":"Lu","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib154","series-title":"EpiCluster: end-to-end deep learning model for B cell epitope prediction designed to capture epitope clustering property","author":"Choi","year":"2023"},{"key":"10.1016\/j.apsb.2025.04.026_bib155","first-page":"448","article-title":"EpiDope: a deep neural network for linear B-cell epitope prediction","volume":"37","author":"Collatz","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib156","first-page":"4027","article-title":"BepFAMN: a method for linear B-cell epitope predictions based on fuzzy-ARTMAP artificial neural network","volume":"22","author":"La Marca","year":"2022","journal-title":"Sensors"},{"key":"10.1016\/j.apsb.2025.04.026_bib157","first-page":"981","article-title":"Design of amyloidogenic peptide traps","volume":"20","author":"Sahtoe","year":"2024","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.apsb.2025.04.026_bib158","article-title":"De novo designed protein inhibitors of amyloid aggregation and seeding","volume":"119","author":"Murray","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.04.026_bib159","article-title":"Atomically accurate de novo design of antibodies with RFdiffusion","author":"Bennett","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib160","first-page":"2603","article-title":"De novo design of a \u03b2-helix Tau protein scaffold: an oligomer-selective vaccine immunogen candidate for Alzheimer\u2019s disease","volume":"14","author":"Aina","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib161","article-title":"Computational design of epitope-specific functional antibodies","volume":"25","author":"Nimrod","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2025.04.026_bib162","article-title":"Integrating machine learning-based virtual screening with multiple protein structures and bio-assay evaluation for discovery of novel GSK3beta inhibitors","volume":"11","author":"Zhu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.026_bib163","first-page":"239","article-title":"Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis","volume":"34","author":"Kumar","year":"2016","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.apsb.2025.04.026_bib164","article-title":"Structure-based virtual screening for the inhibition and clearance of amyloidosis by small molecules as pharmacological chaperones","volume":"9","author":"Sun","year":"2023","journal-title":"Europ J Med Chem Rep"},{"key":"10.1016\/j.apsb.2025.04.026_bib165","first-page":"748","article-title":"Machine learning models for drug-target interactions: current knowledge and future directions","volume":"25","author":"D\u2019Souza","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib166","first-page":"14011","article-title":"Generative models for de novo drug design","volume":"64","author":"Tong","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib167","first-page":"2707","article-title":"De novo molecular design and generative models","volume":"26","author":"Meyers","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib168","first-page":"63","article-title":"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models","volume":"43","author":"Ren","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.04.026_bib169","first-page":"268","article-title":"Automatic chemical design using a data-driven continuous representation of molecules","volume":"4","author":"Gomez-Bombarelli","year":"2018","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib170","series-title":"Junction tree variational autoencoder for molecular graph generation","author":"Jin","year":"2018"},{"key":"10.1016\/j.apsb.2025.04.026_bib171","series-title":"MolGAN: an implicit generative model for small molecular graphs","author":"De Cao","year":"2018"},{"key":"10.1016\/j.apsb.2025.04.026_bib172","first-page":"74","article-title":"A de novo molecular generation method using latent vector based generative adversarial network","volume":"11","author":"Prykhodko","year":"2019","journal-title":"J Cheminf"},{"key":"10.1016\/j.apsb.2025.04.026_bib173","first-page":"20","article-title":"Reinvent 4: modern AI-driven generative molecule design","volume":"16","author":"Loeffler","year":"2024","journal-title":"J Cheminf"},{"key":"10.1016\/j.apsb.2025.04.026_bib174","first-page":"33","article-title":"Multi-objective de novo drug design with conditional graph generative model","volume":"10","author":"Li","year":"2018","journal-title":"J Cheminf"},{"key":"10.1016\/j.apsb.2025.04.026_bib175","series-title":"A generative model for molecular distance geometry","author":"Simm","year":"2019"},{"key":"10.1016\/j.apsb.2025.04.026_bib176","series-title":"DecompDiff: diffusion models with decomposed priors for structure-based drug design","author":"Guan","year":"2024"},{"key":"10.1016\/j.apsb.2025.04.026_bib177","first-page":"8312","article-title":"SyntaLinker: automatic fragment linking with deep conditional transformer neural networks","volume":"11","author":"Yang","year":"2020","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib178","first-page":"3601","article-title":"A foundation model for clinician-centered drug repurposing","volume":"30","author":"Huang","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib179","article-title":"Leveraging generative AI to prioritize drug repurposing candidates: validating identified candidates for Alzheimer\u2019s disease in real-world clinical datasets","author":"Yan","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib180","first-page":"256","article-title":"How thalidomide works against cancer","volume":"343","author":"Medicine","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.026_bib181","first-page":"1096","article-title":"Amantadine: the journey from fighting flu to treating Parkinson disease","volume":"78","author":"Hubsher","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.apsb.2025.04.026_bib182","first-page":"661","article-title":"Drug repositioning and repurposing for Alzheimer disease","volume":"16","author":"Ballard","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib183","article-title":"Memantine: updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Karimi","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.apsb.2025.04.026_bib184","first-page":"7","article-title":"Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer\u2019s disease","volume":"14","author":"Fang","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.apsb.2025.04.026_bib185","unstructured":"Xu J, Hou Y, Zhou Y, Hu M, Cheng F. A network-based deep learning framework catalyzes GWAS and multi-omics findings to biology and drug repurposing for Alzheimer's disease. bioRxiv 2021. Available from: https:\/\/doi.org\/10.1101\/2021.10.20.465087."},{"key":"10.1016\/j.apsb.2025.04.026_bib186","article-title":"Relational inductive biases, deep learning, and graph networks","author":"Battaglia","year":"2018","journal-title":"ArXiv"},{"key":"10.1016\/j.apsb.2025.04.026_bib187","first-page":"1350","article-title":"Compound-protein interaction prediction by deep learning: databases, descriptors and models","volume":"27","author":"Du","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib188","first-page":"118","article-title":"A comprehensive comparison of deep learning-based compound-target interaction prediction models to unveil guiding design principles","volume":"16","author":"Abdollahi","year":"2024","journal-title":"J Cheminf"},{"key":"10.1016\/j.apsb.2025.04.026_bib189","first-page":"331","article-title":"Machine learning-based modeling to predict inhibitors of acetylcholinesterase","volume":"26","author":"Sandhu","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.apsb.2025.04.026_bib190","article-title":"Recognizing novel drugs against Keap1 in Alzheimer\u2019s disease using machine learning grounded computational studies","volume":"15","author":"Mukerjee","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib191","article-title":"AlzhCPI: a knowledge base for predicting chemical-protein interactions towards Alzheimer\u2019s disease","volume":"12","author":"Fang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.04.026_bib192","first-page":"1501","article-title":"Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Dhamodharan","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.apsb.2025.04.026_bib193","article-title":"Multi-target QSAR modeling for the identification of novel inhibitors against Alzheimer\u2019s disease","volume":"233","author":"Kumar","year":"2023","journal-title":"Chemometr Intell Lab Syst"},{"key":"10.1016\/j.apsb.2025.04.026_bib194","first-page":"1936","article-title":"Computational modeling of beta-secretase 1 (BACE-1) inhibitors using ligand based approaches","volume":"56","author":"Subramanian","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2025.04.026_bib195","first-page":"4406","article-title":"TransformerCPI: improving compound-protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments","volume":"36","author":"Chen","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib196","first-page":"985","article-title":"PharmaBench: enhancing ADMET benchmarks with large language models","volume":"11","author":"Niu","year":"2024","journal-title":"Sci Data"},{"key":"10.1016\/j.apsb.2025.04.026_bib197","first-page":"776","article-title":"Evaluation of free online ADMET tools for academic or small biotech environments","volume":"28","author":"Dulsat","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2025.04.026_bib198","first-page":"89","article-title":"BDDCS, the rule of 5 and drugability","volume":"101","author":"Benet","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib199","first-page":"148","article-title":"Evaluation of blockbuster drugs under the rule-of-five","volume":"65","author":"Gimenez","year":"2010","journal-title":"Pharmazie"},{"issue":"Suppl 5","key":"10.1016\/j.apsb.2025.04.026_bib200","first-page":"1065","article-title":"Prediction of rodent carcinogenicity using the DEREK system for 30 chemicals currently being tested by the National Toxicology Program. The DEREK Collaborative Group","volume":"104","author":"Marchant","year":"1996","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.apsb.2025.04.026_bib201","first-page":"321","article-title":"Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive estimate of risk from existing knowledge. Toxicity prediction by komputer assisted technology","volume":"17","author":"Cariello","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1016\/j.apsb.2025.04.026_bib202","series-title":"Learning attributed graph representations with communicative message passing transformer","author":"Chen","year":"2021"},{"key":"10.1016\/j.apsb.2025.04.026_bib203","first-page":"27","article-title":"Double-head transformer neural network for molecular property prediction","volume":"15","author":"Song","year":"2023","journal-title":"J Cheminf"},{"key":"10.1016\/j.apsb.2025.04.026_bib204","first-page":"bbab109","article-title":"An effective self-supervised framework for learning expressive molecular global representations to drug discovery","volume":"22","author":"Li","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2025.04.026_bib205","article-title":"FP-GNN: a versatile deep learning architecture for enhanced molecular property prediction","volume":"23","author":"Cai","year":"2022","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.apsb.2025.04.026_bib206","series-title":"Uni-Mol: a universal 3D molecular representation learning framework. ChemRxiv","author":"Zhou","year":"2022"},{"key":"10.1016\/j.apsb.2025.04.026_bib207","series-title":"One transformer can understand both 2D & 3D molecular data. arXiv","author":"Luo","year":"2022"},{"key":"10.1016\/j.apsb.2025.04.026_bib208","first-page":"W422","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib209","first-page":"1067","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib210","first-page":"408","article-title":"ADMETboost: a web server for accurate ADMET prediction","volume":"28","author":"Tian","year":"2022","journal-title":"J Mol Model"},{"key":"10.1016\/j.apsb.2025.04.026_bib211","first-page":"889","article-title":"vNN web server for ADMET predictions","volume":"8","author":"Schyman","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.026_bib212","first-page":"4066","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib213","first-page":"3658","article-title":"FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery","volume":"33","author":"Lagorce","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib214","first-page":"1189","article-title":"Greedy function approximation: a gradient boosting machine","author":"Friedman","year":"2001","journal-title":"Ann Stat"},{"key":"10.1016\/j.apsb.2025.04.026_bib215","article-title":"A Recurrent Neural Network model to predict blood\u2013brain barrier permeability","volume":"89","author":"Alsenan","year":"2020","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib216","first-page":"2826","article-title":"Relational graph convolutional networks for predicting blood\u2013brain barrier penetration of drug molecules","volume":"38","author":"Ding","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib217","first-page":"325","article-title":"Reinforcement learning model for optimizing dexmedetomidine dosing to prevent delirium in critically ill patients","volume":"7","author":"Lee","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib218","first-page":"1054","article-title":"Reinforcement learning: an introduction","volume":"9","author":"Sutton","year":"1998","journal-title":"IEEE Trans Neural Network"},{"key":"10.1016\/j.apsb.2025.04.026_bib219","first-page":"112","article-title":"Therapeutic proteins: developments, progress, challenges, and future perspectives","volume":"14","author":"Kumar","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.apsb.2025.04.026_bib220","first-page":"2411","article-title":"Engineering protein-based therapeutics through structural and chemical design","volume":"14","author":"Ebrahimi","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2025.04.026_bib222","first-page":"9","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib223","article-title":"Navigating the dementia landscape: biomarkers and emerging therapies","volume":"94","author":"Maheshwari","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib225","first-page":"1","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib226","first-page":"156","article-title":"Antibody engineering and its therapeutic applications","volume":"42","author":"Kandari","year":"2023","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.apsb.2025.04.026_bib227","first-page":"49","article-title":"Robust deep learning-based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.04.026_bib228","first-page":"175","article-title":"Computational and artificial intelligence-based methods for antibody development","volume":"44","author":"Kim","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib229","first-page":"484","article-title":"Mastering the game of Go with deep neural networks and tree search","volume":"529","author":"Silver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib230","first-page":"115","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2025.04.026_bib231","first-page":"1624","article-title":"High-resolution modeling of antibody structures by a combination of bioinformatics, expert knowledge, and molecular simulations","volume":"82","author":"Shirai","year":"2014","journal-title":"Proteins"},{"key":"10.1016\/j.apsb.2025.04.026_bib232","first-page":"W474","article-title":"RosettaAntibody: antibody variable region homology modeling server","volume":"37","author":"Sircar","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib233","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr Protoc Bioinform"},{"key":"10.1016\/j.apsb.2025.04.026_bib234","first-page":"1089","article-title":"Empirical scoring functions for structure-based virtual screening: applications, critical aspects, and challenges","volume":"9","author":"Guedes","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.026_bib235","first-page":"1711","article-title":"Applying and improving AlphaFold at CASP14","volume":"89","author":"Jumper","year":"2021","journal-title":"Proteins"},{"key":"10.1016\/j.apsb.2025.04.026_bib236","first-page":"14","article-title":"Predicting molecular docking of per- and polyfluoroalkyl substances to blood protein using generative artificial intelligence algorithm DiffDock","volume":"76","author":"Fortela","year":"2024","journal-title":"Biotechniques"},{"key":"10.1016\/j.apsb.2025.04.026_bib237","first-page":"e3","article-title":"De novo protein design, a retrospective","volume":"53","author":"Korendovych","year":"2020","journal-title":"Q Rev Biophys"},{"key":"10.1016\/j.apsb.2025.04.026_bib238","article-title":"Recent advances in de novo protein design: Principles, methods, and applications","volume":"296","author":"Pan","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib239","first-page":"665","article-title":"Macromolecular modeling and design in Rosetta: recent methods and frameworks","volume":"17","author":"Leman","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2025.04.026_bib240","first-page":"1089","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.04.026_bib241","article-title":"RosettaScripts: a scripting language interface to the Rosetta macromolecular modeling suite","volume":"6","author":"Fleishman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.04.026_bib242","first-page":"2603","article-title":"De novo design of a beta-helix tau protein scaffold: an oligomer-selective vaccine immunogen candidate for Alzheimer\u2019s disease","volume":"14","author":"Aina","year":"2023","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib243","first-page":"653","article-title":"A powerful and flexible weighted distance-based method incorporating interactions between DNA methylation and environmental factors on health outcomes","volume":"36","author":"Wang","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib244","article-title":"Application of a collagen scaffold saturated with platelet-rich plasma in prevention of bisphosphonate-related osteonecrosis of the jaw in the rat animal model","volume":"7","author":"Razmara","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.apsb.2025.04.026_bib245","first-page":"2016","article-title":"Descriptor-free QSAR: effectiveness in screening for putative inhibitors of FGFR1","volume":"41","author":"Joel","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.apsb.2025.04.026_bib246","first-page":"W345","article-title":"PrankWeb: a web server for ligand binding site prediction and visualization","volume":"47","author":"Jendele","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib247","article-title":"Aggregation of therapeutic monoclonal antibodies due to thermal and air\/liquid interfacial agitation stress: occurrence, stability assessment strategies, aggregation mechanism, influencing factors, and ways to enhance stability","volume":"666","author":"Sreenivasan","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.04.026_bib248","first-page":"1004","article-title":"Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies","volume":"2","author":"Lundahl","year":"2021","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.apsb.2025.04.026_bib249","article-title":"Protein solubility predictions using the camsol method in the study of protein homeostasis","volume":"11","author":"Sormanni","year":"2019","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.apsb.2025.04.026_bib250","first-page":"1445","article-title":"SOLart: a structure-based method to predict protein solubility and aggregation","volume":"36","author":"Hou","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib251","first-page":"W300","article-title":"Aggrescan3D (A3D) 2.0: prediction and engineering of protein solubility","volume":"47","author":"Kuriata","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib252","first-page":"4041","article-title":"Humanization of antibodies using a machine learning approach on large-scale repertoire data","volume":"37","author":"Marks","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib253","article-title":"BioPhi: a platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning","volume":"14","author":"Prihoda","year":"2022","journal-title":"MAbs"},{"key":"10.1016\/j.apsb.2025.04.026_bib254","series-title":"Handbook of biomarkers and precision medicine","year":"2019"},{"key":"10.1016\/j.apsb.2025.04.026_bib255","article-title":"Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach","volume":"10","author":"Soleimani Zakeri","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.04.026_bib256","first-page":"8088","article-title":"Relationship between dementia and gut microbiome-associated metabolites: a cross-sectional study in Japan","volume":"10","author":"Saji","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2025.04.026_bib257","first-page":"21","article-title":"A comprehensive systematic review of CSF proteins and peptides that define Alzheimer\u2019s disease","volume":"17","author":"Pedrero-Prieto","year":"2020","journal-title":"Clin Proteom"},{"key":"10.1016\/j.apsb.2025.04.026_bib258","article-title":"Resting state EEG biomarkers of cognitive decline associated with Alzheimer\u2019s disease and mild cognitive impairment","volume":"16","author":"Meghdadi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2025.04.026_bib259","first-page":"21","article-title":"Neuroimaging biomarkers for Alzheimer\u2019s disease","volume":"14","author":"Marquez","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.apsb.2025.04.026_bib260","first-page":"552","article-title":"Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer\u2019s disease?.","volume":"39","author":"Mander","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib261","first-page":"537","article-title":"A metabolomic approach to identifying biomarkers in blood of Alzheimer\u2019s disease","volume":"6","author":"Lin","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib262","first-page":"414","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2025.04.026_bib263","first-page":"641","article-title":"The role of biomarkers and imaging in the clinical diagnosis of dementia","volume":"47","author":"Bayer","year":"2018","journal-title":"Age Ageing"},{"key":"10.1016\/j.apsb.2025.04.026_bib264","first-page":"11847","article-title":"AI-assisted identification of primary and secondary metabolomic markers for postoperative delirium","volume":"25","author":"Ivanisenko","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib265","series-title":"Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining","article-title":"XGBoost","author":"Chen","year":"2016"},{"key":"10.1016\/j.apsb.2025.04.026_bib266","series-title":"Proceedings of the MLSDA 2014 2nd workshop on machine learning for sensory data analysis","article-title":"Anomaly detection using autoencoders with nonlinear dimensionality reduction","author":"Sakurada","year":"2014"},{"key":"10.1016\/j.apsb.2025.04.026_bib267","first-page":"3371","article-title":"Stacked denoising autoencoders: learning useful representations in a deep network with a local denoising criterion","volume":"11","author":"Vincent","year":"2010","journal-title":"J Mach Learn Res"},{"key":"10.1016\/j.apsb.2025.04.026_bib268","first-page":"9","article-title":"Digital biomarkers for Alzheimer\u2019s disease: the mobile\/wearable devices opportunity","volume":"2","author":"Kourtis","year":"2019","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib269","first-page":"157","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib270","first-page":"440","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.apsb.2025.04.026_bib271","first-page":"857","article-title":"Imaging and machine learning techniques for diagnosis of Alzheimer\u2019s disease","volume":"27","author":"Mirzaei","year":"2016","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.apsb.2025.04.026_bib272","first-page":"8867","article-title":"Employing deep-learning approach for the early detection of mild cognitive impairment transitions through the analysis of digital biomarkers","volume":"23","author":"Narasimhan","year":"2023","journal-title":"Sensors"},{"key":"10.1016\/j.apsb.2025.04.026_bib273","article-title":"Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer\u2019s disease","volume":"24","author":"Archetti","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.apsb.2025.04.026_bib274","first-page":"99","article-title":"Data harmonisation for information fusion in digital healthcare: a state-of-the-art systematic review, meta-analysis and future research directions","volume":"82","author":"Nan","year":"2022","journal-title":"Inf Fusion"},{"key":"10.1016\/j.apsb.2025.04.026_bib275","first-page":"29","article-title":"Unbox the black-box for the medical explainable AI via multi-modal and multi-centre data fusion: a mini-review, two showcases and beyond","volume":"77","author":"Yang","year":"2022","journal-title":"Inf Fusion"},{"key":"10.1016\/j.apsb.2025.04.026_bib276","article-title":"A new generation of AD biomarkers: 2019 to 2021","volume":"79","author":"Hawksworth","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib277","first-page":"e399","article-title":"Delirium, neurofilament light chain, and progressive cognitive impairment: analysis of a prospective Norwegian population-based cohort","volume":"4","author":"Krogseth","year":"2023","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.apsb.2025.04.026_bib278","first-page":"e232","article-title":"The effect of baseline cognition and delirium on long-term cognitive impairment and mortality: a prospective population-based study","volume":"3","author":"Tsui","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/j.apsb.2025.04.026_bib279","first-page":"513","article-title":"MoleculeNet: a benchmark for molecular machine learning","volume":"9","author":"Wu","year":"2018","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib280","first-page":"112","article-title":"Opportunities and challenges in developing relevant animal models for Alzheimer\u2019s disease","volume":"26","author":"De Felice","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib281","first-page":"2150","article-title":"Preclinical and translational models for delirium: recommendations for future research from the NIDUS delirium network","volume":"19","author":"Vasunilashorn","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.apsb.2025.04.026_bib282","author":"Sartor"},{"key":"10.1016\/j.apsb.2025.04.026_bib283","first-page":"9260","article-title":"How good are current pocket-based 3D generative models?: the benchmark set and evaluation of protein pocket-based 3D molecular generative models","volume":"64","author":"Liu","year":"2024","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.apsb.2025.04.026_bib284","article-title":"Pre-training of equivariant graph matching networks with conformation flexibility for drug binding","volume":"9","author":"Wu","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.apsb.2025.04.026_bib285","article-title":"Quantum computing for near-term applications in generative chemistry and drug discovery","volume":"28","author":"Pyrkov","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib286","first-page":"i228","article-title":"DrugComboRanker: drug combination discovery based on target network analysis","volume":"30","author":"Huang","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.apsb.2025.04.026_bib287","article-title":"Network-based prediction of anti-cancer drug combinations","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2025.04.026_bib288","article-title":"Memantine for dementia","volume":"3","author":"McShane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apsb.2025.04.026_bib289","article-title":"How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons","volume":"29","author":"Kp","year":"2024","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2025.04.026_bib290","article-title":"Artificial intelligence in small molecule drug discovery from 2018 to 2023: does it really work?.","volume":"141","author":"Lv","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2025.04.026_bib292","first-page":"895","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2025.04.026_bib293","first-page":"45","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.04.026_bib294","first-page":"747","article-title":"Artificial intelligence in cancer research, diagnosis and therapy","volume":"21","author":"Elemento","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.04.026_bib295","first-page":"156","article-title":"A systematic review of trustworthy and explainable artificial intelligence in healthcare: assessment of quality, bias risk, and data fusion","volume":"96","author":"Albahri","year":"2023","journal-title":"Inform Fusion"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525002886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T05:32:03Z","timestamp":1758605523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525002886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":289,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2211383525002886"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.026","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence in drug development for delirium and Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}